Polycystic Ovary Syndrome: all 975 studies

Page 8 of 10. Open to participants first (177), then studies with results posted, then the rest; newest registration first within each.

• Extended Clomiphene Citrate Regimen in Women With Polycystic Ovary SyndromeCompletedNCT02381184Phase 2/3
• Phytoestrogens as an Alternative to Estradiol in Ovulation Induction in PCOSCompletedNCT02352597Phase 4
• Adding Prednisolone During Ovulation Induction With CC in Lean Women With CC Resistant PCOSStatus unknownNCT02344888Phase 4
• Ovulation Induction in Clomiphene Citrate Resistant PCO WomenCompletedNCT02341703Early Phase 1
• The Influence Factors of Ovarian Response in PCOS Patients With IVF-ET TreatmentStatus unknownNCT02331758Not applicable
• Auricular Acupressure (AA) For Overweight/Obese Adolescent and Young Polycystic Ovary Syndrome ( PCOS)Status unknownNCT02326714Not applicable
• Comparison Between Letrozole and Laparoscopic Ovarian Drilling in Women With Clomiphene Resistant Polycystic Ovarian Syndrome (PCOS)Status unknownNCT02305693Phase 3
• Comparison Between Laparoscopic Ovarian Diathermy and Urinary Purified FSH in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome.Status unknownNCT02304536Phase 3
• Comparison Between Letrozole and Urinary Purified FSH in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome.CompletedNCT02304107Phase 3
• PCOS & Insulin Resistance Exercise StudyActive, not recruitingNCT02303470Not applicable
• Involvement of Reticulum Endoplasmic Stress in the Physiopathology of Polycystic Ovary SyndromeCompletedNCT02302326Not applicable
• Trial With Metformin in Women With Polycystic Ovary SyndromeCompletedNCT02280057Phase 4
• HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS PatientsCompletedNCT02273791
• Endocrine Disrupting Chemicals: Potential Effects on Male and Female Reproductive Health in SaskatchewanCompletedNCT02272439
• Predictors of Ovarian Response During Clomiphene Citrate Ovulation Induction in Patients With Polycystic Ovary SyndromeCompletedNCT02269306Not applicable
• Response of VEGF and AT-II to HCG in PCOSCompletedNCT02265861Early Phase 1
• Endobarrier Treatment in Women With PCOSStatus unknownNCT02255578Phase 3
• Effect of Meal Frequency on Glycemic Control of People at High Risk or Diagnosed With DiabetesCompletedNCT02248272Not applicable
• Effect of Metformin Therapy on Serum Under-carboxylated Osteocalcin Levels in Hyperandrogenic Lean Polycystic Ovarian Syndrome WomenStatus unknownNCT02244567Phase 1
• N-acetyl Cysteine for Ovulation Induction in Clomiphene Citrate Resistant Polycystic Ovary SyndromeCompletedNCT02239107Phase 4
• Use of Myo-inositol as Adjuvant Therapy in Patients With Polycystic Ovary Syndrome (PCOS) in Vitro Fertilization (IVF)TerminatedNCT02221154Phase 4
• Metformin Treatment in Polycystic Ovary Syndrome (PCOS)Status unknownNCT02198417Not applicable
• Paleo Versus Healthy ADA Diets for Treatment of Polycystic Ovarian Syndrome (PCOS)CompletedNCT02190097Not applicable
• Comparison Between the Role of Follicular Output Rate and Preovulatory Count in the Prediction of Pregnancy in Women With Polycystic Ovarian Syndrome Undergoing Intra Cytoplasmic Sperm Injection (ICSI)Status unknownNCT02190006
• PDE-4 Inhibitor Roflumilast and GLP-1 Agonist Liraglutide in Polycystic Ovary SyndromeCompletedNCT02187250Phase 4
• Screening for GDM in Women With PCOS and ControlsCompletedNCT02183558Not applicable
• Effect of Magnesium Supplementation on Polycystic Ovary SyndromeStatus unknownNCT02178150Not applicable
• Vitamin D Status in Relation to Insulin Sensitivity Among Saudi Women With Polycystic Ovary SyndromeStatus unknownNCT02164552
• Evaluation of the Role of Follicular Sensitivity Index in the Prediction of Pregnancy in Women Undergoing ICSI/IVF Without Polycystic Ovarian SyndromeStatus unknownNCT02158026
• Endometrial Scratching During Laproscopic Ovarian Drilling in Subfertile PCOS WomenStatus unknownNCT02140398Phase 4
• Effect of Bromocriptine on Insulin Resistance in Polycystic Ovarian Syndrome - A Pilot StudyStatus unknownNCT02133755Phase 3
• The Secretion of Incretin Hormones in Patients With Polycystic Ovary SyndromeStatus unknownNCT02126592
• Androgen Metabolism and Reproductive OutcomeCompletedNCT02106676
• Potential Impact of Polycystic Ovarian Syndrome on Protein Modifications and AccumulationCompletedNCT02105428Not applicable
• Mathematical Model for the Human Menstrual Cycle, Endocrinological Diseases and Fertility Treatment-PAEONCompletedNCT02098668
• Serum Ghrelin in Polycystic Ovary SyndromeStatus unknownNCT02087410
• Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET)CompletedNCT02086526Phase 1
• A New Algorithm to Predict Ovarian AgeStatus unknownNCT02086318
• Long Acting GnRH Antagonist in PCOS Women Undergoing IVFStatus unknownNCT02084940
• Gut Microbiome in Patients With Polycystic Ovary SyndromeStatus unknownNCT02078505Not applicable
• Insulin Differences Between African-American and Caucasian Female Adolescents With Polycystic Ovary Syndrome (PCOS)TerminatedNCT02052479Not applicable
• PDE-4 Inhibitor Roflumilast and Polycystic Ovary SyndromeCompletedNCT02037672Phase 4
• Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by AntioxidantsStatus unknownNCT02027337Phase 4
• The Effect of Acupuncture on Insulin Sensitivity Polycystic Ovary SyndromeStatus unknownNCT02026323Not applicable
• PCOS Treatment Using DLBS3233, Metformin, and Combination of BothCompletedNCT01999686Phase 3
• IR, Inflammatory and Cardiovascular Markers in PCOS Among Obese and Non-obese WomenStatus unknownNCT01989039
• Obstetric Outcomes in Women With PCOSCompletedNCT01983202
• Evaluation of the Goldstein SonoBiopsy™ Catheter for Diagnosing Endometrial PathologyTerminatedNCT01969396Not applicable
• Effect of Progestin-Induced Withdrawal Bleed on Ovulation Induction Cycles With Clomiphene CitrateWithdrawnNCT01966575Phase 4
• The Effect of Cipralex on Quality of Life, Adrenal Activity Glucose Metabolism, Physical and Mental Health in PCOSCompletedNCT01961180Phase 4
• Clomiphene Stair-Step Protocol for Ovulation Induction in Women With Polycystic Ovarian SyndromeCompletedNCT01953796Not applicable
• The Influence of Polycystic Ovairan Syndrome on Embryonic Developmental TimingCompletedNCT01953146
• Presentations of Hyperandrogenic Phenotypes in Taiwanese WomenCompletedNCT01940666
• Nutritional and Metabolic Correlates of Ovarian Morphology in Women With Polycystic Ovary SyndromeCompletedNCT01927471
• Ultrasound Characterization of Ovarian Follicle Dynamics in Women With AmenorrheaCompletedNCT01927432
• High Intensity Interval Training or Strength Training in Women With Polycystic Ovary SyndromeCompletedNCT01919281Not applicable
• Polycystic Ovary Syndrome and Liraglutide as Add-on Therapy on MetforminCompletedNCT01911468Phase 4
• Coenzyme Q10 and Clomiphene Citrate (CC) for Ovulation Induction in Polycystic Ovary SyndromeCompletedNCT01910766Not applicable
• Polycystic Ovary Syndrome and LiraglutideCompletedNCT01899430Phase 4
• Mood and Nutrition Interventions in Polycystic Ovary SyndromeCompletedNCT01899001Not applicable
• Incretin Effect in PCOS WomenCompletedNCT01892254Phase 4
• The Use Of AMH for the Discrimination of Polycystic and Multicystic Ovaries in Nonhyperandrogenic PatientsStatus unknownNCT01878955
• Comparison of Lifestyle Markers Between Women With and Without Polycystic Ovary SyndromeCompletedNCT01859663
• Serum Anti-Mullerian Hormone (AMH) Levels in Overweight and Obese Adolescent Girls With Polycystic OvariesCompletedNCT01856894
• In Vitro Maturation (IVM) of Human OocytesWithdrawnNCT01843569Not applicable
• Live Birth After Fresh Embryo Transfer Vs Frozen-thawed Embryo Transfer in Women With Polycystic Ovary SyndromeStatus unknownNCT01841528Not applicable
• Effect of Obstructive Sleep Apnea Syndrome on Insulin Sensitivity and Cardiovascular Risk in PCOS AdolescentsCompletedNCT01840618
• Prevalence of HbA1C in Women With PCOSStatus unknownNCT01838122
• Effect of Low-frequency Electroacupuncture (EA) on Polycystic Ovary SyndromeCompletedNCT01812161Not applicable
• Clomiphene Citrate Plus uFSH Versus Aromatase Inhibitor Plus uFSH in Clomiphene Resistant Infertile PCOS WomenStatus unknownNCT01793038Not applicable
• Myo-inositol Versus Metformin in Obese Women With Polycystic Ovary SyndromeCompletedNCT01791647Not applicable
• Effect of Weight & Insulin Sensitivity on Reproductive Function in PCOS: Studies in Skeletal Muscle & AdiposeTerminatedNCT01775176
• Assessment of Cod Protein as an Insulin-sensitizing Agent in Women With Polycystic Ovary Syndrome.CompletedNCT01766557Not applicable
• the Effect of Diane-35 Pretreatment on In-vitro Fertilization Outcome for Patients With Polycystic Ovary SyndromeStatus unknownNCT01752270Phase 4
• Adipose Tissue and Polycystic Ovary Syndrome (PCOS)(EIFFEL)Active, not recruitingNCT01745471
• THE ASSOCIATION BETWEEN FATTY LIVER (NAFLD) DISEASE AND PCOSStatus unknownNCT01735799
• Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS)CompletedNCT01733459Phase 3
• Vitamin D Treatment, Pharmacogenetics and Glucose MetabolismCompletedNCT01721915Phase 4
• Effects of Micronized Trans-resveratrol Treatment on Polycystic Ovary Syndrome (PCOS) PatientsStatus unknownNCT01720459Not applicable
• Healthy Eating for Reproductive Health: GreenvilleWithdrawnNCT01716429Not applicable
• Meal Timing on Glucose and Hyperandrogenism in PCOS WomenStatus unknownNCT01711476Not applicable
• Study to Compare Between Combimed Metformin-letrozole and Ovarian Drilling in Pcos With Bilateral Ovarian Drilling in Clomiphene-resistant Infertile Women With Polycystic Ovarian SyndromeCompletedNCT01693289Phase 1
• Letrozole or Combined Clomiphene Citrate Metformin as a First Line Treatment in Women With Polycystic Ovarian SyndromeCompletedNCT01679574Not applicable
• Ovarian Stimulation and Intrauterine Insemination in Women With Polycystic Ovarian SyndromeCompletedNCT01675843Phase 4
• Medical Nutrition Therapy Plus Transgestational Metformin For Preventing Gestational Diabetes In High Risk Mexican WomenCompletedNCT01675310Phase 4
• Plasma Levels of GDF-9 and GDF-15 in Patients With Polycystic Ovary Syndrome.CompletedNCT01644305
• Clomifene Citrate Versus Metformin in First-line Treatment of Infertility in Patients With Polycystic Ovary Syndrome and a Resistance to InsulinWithdrawnNCT01638988Phase 3
• GnRH Agonist (GnRHa) Withdrawal at Late Stage of Long Protocol and the Incidence of Ovarian Hyper-stimulationStatus unknownNCT01634724Not applicable
• Comparison Between Mediterranean Diet and High Protein Diet in Women With Polycystic Ovary Syndrome (PCOS)Status unknownNCT01615848Not applicable
• Blood Vessel Function in Adolescents and Women With Polycystic Ovary SyndromeTerminatedNCT01615562
• Effects of Drospirenone-ethinylestradiol and/or NOMAC-valerate Estradiol on Cardiovascular Risk in Women With Polycystic Ovary SyndromeStatus unknownNCT01603745Phase 1
• Oxidative Stress and Bisphenol A (BPA) Impact With Polycystic Ovary Syndrome (PCOS)Status unknownNCT01600872
• The Association of Ferrtin and Homocysteine Etc. With RI and MS in Polycystic Ovary Syndrome (PCOS)CompletedNCT01600833
• Metformin in Pregnancy in Women With Polycystic Ovary SyndromeCompletedNCT01594697Not applicable
• Contraceptive Pill and Hormonal Vaginal Ring in Women With Polycystic Ovary SyndromeStatus unknownNCT01588873Phase 4
• Metformin to Prevent Late Miscarriage and Preterm Delivery in Women With Polycystic Ovary SyndromeCompletedNCT01587378Not applicable
• Effects of Drospirenone-ethinylestradiol and/or Metformin on Cardiovascular Risk in Hyperinsulinemic Women With Polycystic Ovary SyndromeCompletedNCT01581814Phase 3
• The Effects of Letrozole And Clomiphene Citrate For Induction of Ovulation In Polycystic Ovarian Syndrome(PCOS)CompletedNCT01577017Phase 3
• Could the Therapy With Inositol Affect the Cardiovascular Risk in PCOS Women? Results of a Randomized Clinical TrialStatus unknownNCT01574261Early Phase 1
• Acupuncture and Clomiphene Citrate on Live Birth in Anovulatory Women With Polycystic Ovary SyndromeCompletedNCT01573858Not applicable

← Polycystic Ovary Syndrome overview